Department of Immunology, Genetics and Pathology at Uppsala University

The Department of Immunology, Genetics and Pathology at Uppsala University has a broad research profile with strong research groups focused on cancer, genetic and autoimmune diseases. One of the core ideas at the department is to stimulate translational research and thus promote closer collaboration between medical research and healthcare. Research is conducted within six research programs: cancer precision medicine, cancer immunotherapy, genomics and neurobiology, molecular tools and functional genomics, neuro-oncology and neurodegeneration, and vascular biology. Parts of the operations are also integrated with the departments of oncology, clinical genetics, clinical immunology, clinical pathology, and hospital physics at Uppsala University Hospital. The department has teaching assignments in several program educations, independent courses, and international master's programs within the medical faculty. The department has a turnover of approximately 550 million SEK, of which about two-thirds are external research grants. The number of employees is about 400, of which about 100 are doctoral students, and there are a total of over 850 active in the workforce. Please read more about the department's activities here: http://www.uu.se/medarbetare/institution/immunologi-genetik-och-patologi (http://www.uu.se/medarbetare/institution/immunologi-genetik-och-patologi)

Job Responsibilities

The Islet Cell Laboratory serves as a central hub for isolating insulin-producing cells for transplantation at all transplantation centers in Scandinavia. Transplantation occurs for patients with the most severe form of Type 1 Diabetes as well as for patients who have suffered various injuries to their pancreas. The laboratory is an important part of diabetes care in the Nordic countries. Your work will take place in clean rooms and will encompass all steps in the process from receiving the pancreas to the transplantation of the isolated insulin-producing cells.

Qualifications

• Fluent in speaking and writing Swedish.
• Documented experience in isolating insulin-producing cells from human pancreas for clinical transplantation.

Desirable and/or Meritorious:

• Experience in work governed by regulatory requirements such as GMP and the tissue directive, as well as experience with supervisory authorities such as Swedac, IVO, and the Medical Products Agency is meritorious.
• Ability to work both independently and in a team.
• Flexible and stress-resistant.

About the Employment

The position is temporary, 11 months with the possibility of extension. The scope is full-time. Start date by agreement. Location: Uppsala

For inquiries about the position, please contact: Olle Korsgren, [email protected] (mailto:[email protected])

Welcome with your application by January 26, 2026, UFV-PA 2026/18

Uppsala University is a broad research university with a strong international position. The ultimate goal is to conduct education and research of the highest quality and relevance to make a difference in society. Our most important asset is all 7,600 employees and 53,000 students who, with curiosity and commitment, make Uppsala University one of the country's most exciting workplaces.

Read more about our benefits and what it is like to work at Uppsala University https://uu.se/om-uu/jobba-hos-oss/ (https://uu.se/om-uu/jobba-hos-oss/)

The employment may be subject to security clearance. A prerequisite for employment is that the applicant is approved during the security clearance.

We kindly decline offers of recruitment and advertising assistance.

Applications are received in Uppsala University's recruitment system.

Union representatives: Saco-S - [email protected] (mailto:[email protected]), Seko - [email protected] (mailto:[email protected]), ST (OFR/S) - [email protected] (mailto:[email protected])